The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Emphysema Treatment Market During The Forecast Period 2026–2030?
The emphysema treatment market has experienced significant expansion over recent years. Its value is expected to rise from $5.4 billion in 2025 to $5.8 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to factors like the increasing prevalence of COPD, a growing smoking population, limited awareness concerning early diagnosis, the adoption of traditional inhalation therapies, and the improving hospital infrastructure in developing regions.
The emphysema treatment market is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $7.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. Key factors driving this growth during the forecast timeframe include breakthroughs in gene therapy, the increasing uptake of digital health solutions, expanding home healthcare services, the emergence of portable oxygen devices, and the rising need for minimally invasive surgical procedures. Significant trends expected throughout this period encompass personalized treatment strategies, home-centric care approaches, minimally invasive treatments, telehealth and remote patient monitoring, along with sophisticated pulmonary rehabilitation programs.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
What Drivers Are Expected To Influence The Emphysema Treatment Market During The Forecast Period?
An anticipated increase in chronic obstructive pulmonary disease (COPD) cases is set to boost the expansion of the emphysema treatment market in the coming years. Chronic obstructive pulmonary disease (COPD) encompasses a group of conditions leading to restricted airflow and respiratory challenges, specifically including emphysema and chronic bronchitis. Emphysema treatments play a crucial role in curbing the progression of Chronic Obstructive Pulmonary Disease (COPD) by concentrating on symptom management, re-establishing lung function, and slowing down the illness’s development. For example, a research study from JAMA Network Open, a medical journal affiliated with the American Medical Association, indicated in December 2023 that the worldwide incidence of chronic obstructive pulmonary disease (COPD) is projected to climb to almost 600 million cases by 2050, representing a 23% rise in its occurrence. Consequently, the growing occurrence of chronic obstructive pulmonary disease (COPD) cases is a key factor driving the emphysema treatment market.
What Market Segments Are Evaluated Within The Emphysema Treatment Market?
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care
What Industry Trends Are Redefining The Emphysema Treatment Market?
Key companies active in the emphysema market are developing innovative offerings such as inhalation aerosols to secure a competitive advantage. Inhalation aerosols are pharmaceutical preparations delivered as a fine mist or spray of liquid medication suspended in a propellant or a blend of propellants. For instance, in July 2023, Viatris Inc., a US-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a US-based pharmaceutical contract development and manufacturing organization (CDMO), released Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This marked the first FDA-approved generic version of AstraZeneca’s Symbicort for patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. This drug-device combination product, provided in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, represents a significant stride in offering accessible and cost-effective treatment alternatives for individuals facing respiratory difficulties. Breyna is formulated to address the maintenance treatment of airflow obstruction, minimize exacerbations in COPD patients, and manage asthma symptoms in patients six years and older, including those with emphysema.
Who Are The Top Market Participants Influencing The Emphysema Treatment Market?
Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.
Read the full emphysema treatment market report here:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Which Region Is Forecast To Lead The Emphysema Treatment Market In Terms Of Market Size?
North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Emphysema Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp
Browse Through More Reports Similar to the Global Emphysema Treatment Market 2026, By The Business Research Company
Emphysema Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Anaphylaxis Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Bronchitis Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model